Abstract:Inflammatory bowel diseases (IBD), including Crohn's disease (CD) and ulcerative colitis (UC), are complex, multifactorial disorders that lead to chronic and relapsing intestinal inflammation. The exact etiology remains unknown, however multiple factors including the environment, genetic, dietary, mucosal immunity, and altered microbiome structure and function play important roles in disease onset and progression. Supporting this notion that the gut microbiota plays a pivotal role in IBD pathogenesis, studies in gnotobiotic mice have shown that mouse models of intestinal inflammation require a microbial community to develop colitis. Additionally, antimicrobial therapy in some IBD patients will temporarily induce remission further demonstrating an association between gut microbes and intestinal inflammation. Finally, a dysfunctional intestinal epithelial barrier is also recognized as a key pathogenic factor in IBD. The intestinal epithelium serves as a barrier between the luminal environment and the mucosal immune system and guards against harmful molecules and microorganisms while being permeable to essential nutrients and solutes. Beneficial (i.e., mutualists) bacteria promote mucosal health by strengthening barrier integrity, increasing local defenses (mucin and IgA production) and inhibiting pro-inflammatory immune responses and apoptosis to promote mucosal homeostasis. In contrast, pathogenic bacteria and pathobionts suppress expression and localization of tight junction proteins, cause dysregulation of apoptosis/proliferation and increase pro-inflammatory signaling that directly damages the intestinal mucosa. This review article will focus on the role of intestinal epithelial cells (IECs) and the luminal environment acting as mediators of barrier function in IBD. We will also share some of our translational observations of interactions between IECs, immune cells, and environmental factors contributing to maintenance of mucosal homeostasis, as it relates to GI inflammation and IBD in different animal models.

New Insights into Bacterial Mechanisms and Potential Intestinal Epithelial Cell Therapeutic Targets of Inflammatory Bowel Disease

Anti-cytokine Therapy and Small Molecule Agents for the Treatment of Inflammatory Bowel Disease

Intestinal microecology dysbiosis in inflammatory bowel disease: Pathogenesis and therapeutic strategies

Innate Lymphoid Cells as Regulators of Epithelial Integrity: Therapeutic Implications for Inflammatory Bowel Diseases

New Insights into the Role of Oral Microbiota Dysbiosis in the Pathogenesis of Inflammatory Bowel Disease

Interplay of Intestinal Microbiota and Mucosal Immunity in Inflammatory Bowel Disease: a Relationship of Frenemies

An (Anti)-Inflammatory Microbiota: Defining the Role in Inflammatory Bowel Disease?

Current Insights on the Roles of Gut Microbiota in Inflammatory Bowel Disease-Associated Extra-Intestinal Manifestations: Pathophysiology and Therapeutic Targets

The microbiome in inflammatory bowel diseases: from pathogenesis to therapy

New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease

Rules of Engagement: Epithelial-Microbe Interactions and Inflammatory Bowel Disease

Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease.

Sentinels at the frontline: the role of intraepithelial lymphocytes in inflammatory bowel disease

The Gut Microbiota In The Pathogenesis And Therapeutics Of Inflammatory Bowel Disease

Microbiota as key factors in inflammatory bowel disease

Restore Intestinal Barrier Integrity: An Approach for Inflammatory Bowel Disease Therapy

Recent advances in inflammatory bowel disease: mucosal immune cells in intestinal inflammation

Innate Lymphoid Cells in Intestinal Homeostasis and Inflammatory Bowel Disease

The emerging role of the gut microbiota and its application in inflammatory bowel disease

Immunology of Inflammatory Bowel Disease: Molecular Mechanisms and Therapeutics

In Inflammatory Bowel Disease and Extraintestinal Manifestations: What Role Does Microbiome Play?